Joëlle Lerable

670 total citations
14 papers, 474 citations indexed

About

Joëlle Lerable is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Joëlle Lerable has authored 14 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Joëlle Lerable's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Joëlle Lerable is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Joëlle Lerable collaborates with scholars based in France and Germany. Joëlle Lerable's co-authors include Martine Mariotti, Jean‐Jacques Lefrère, Laurence Morand‐Joubert, Micheline Thauvin, Robert Girot, Jean‐Claude Petit, François Lefrère, Françoise Roudot‐Thoraval, Guillaume Lefèvre and J.‐J. Lefrère and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Thrombosis and Haemostasis.

In The Last Decade

Joëlle Lerable

14 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joëlle Lerable France	9	316	299	164	114	65	14	474
Micheline Thauvin France	9	210 0.7×	144 0.5×	232 1.4×	121 1.1×	62 1.0×	11	441
Joy Chang United States	11	87 0.3×	157 0.5×	287 1.8×	110 1.0×	70 1.1×	17	548
J. Mellor United Kingdom	9	708 2.2×	788 2.6×	202 1.2×	41 0.4×	25 0.4×	14	952
Niro Ujiie Japan	8	506 1.6×	499 1.7×	99 0.6×	24 0.2×	46 0.7×	13	663
Antigoni Katsoulidou Greece	13	379 1.2×	369 1.2×	198 1.2×	91 0.8×	20 0.3×	21	543
Catherine Dhiver France	8	116 0.4×	95 0.3×	307 1.9×	252 2.2×	62 1.0×	10	570
Jim McMenamin United Kingdom	8	251 0.8×	158 0.5×	170 1.0×	41 0.4×	19 0.3×	11	427
L. F. Barker United States	12	475 1.5×	473 1.6×	186 1.1×	16 0.1×	46 0.7×	27	662
Leopoldo Deibis Venezuela	9	115 0.4×	96 0.3×	195 1.2×	98 0.9×	29 0.4×	19	419
Jeffrey C. Hunt United States	8	284 0.9×	277 0.9×	190 1.2×	235 2.1×	17 0.3×	11	490

Countries citing papers authored by Joëlle Lerable

Since Specialization

Citations

This map shows the geographic impact of Joëlle Lerable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joëlle Lerable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joëlle Lerable more than expected).

Fields of papers citing papers by Joëlle Lerable

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joëlle Lerable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joëlle Lerable. The network helps show where Joëlle Lerable may publish in the future.

Co-authorship network of co-authors of Joëlle Lerable

This figure shows the co-authorship network connecting the top 25 collaborators of Joëlle Lerable. A scholar is included among the top collaborators of Joëlle Lerable based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joëlle Lerable. Joëlle Lerable is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Lefrère, Jean‐Jacques, Robert Girot, François Lefrère, et al.. (2004). Complete or partial seroreversion in immunocompetent individuals after self‐limited HCV infection: consequences for transfusion. Transfusion. 44(3). 343–348. 33 indexed citations

2.

Lefrère, Jean‐Jacques, Françoise Roudot‐Thoraval, François Lefrère, et al.. (2000). Natural history of the TT virus infection through follow-up of TTV DNA–positive multiple-transfused patients. Blood. 95(1). 347–351. 56 indexed citations

3.

Lefrère, Jean‐Jacques, Françoise Roudot‐Thoraval, François Lefrère, et al.. (2000). Natural history of the TT virus infection through follow-up of TTV DNA–positive multiple-transfused patients. Blood. 95(1). 347–351. 2 indexed citations

4.

Lefrère, Jean‐Jacques, Françoise Roudot‐Thoraval, Laurence Morand‐Joubert, et al.. (1999). Prevalence of GB virus type C/hepatitis G virus RNA and of anti‐E2 in individuals at high or low risk for blood‐borne or sexually transmitted viruses: evidence of sexual and parenteral transmission. Transfusion. 39(1). 83–94. 55 indexed citations

5.

Lefrère, Jean‐Jacques, Françoise Roudot‐Thoraval, Laurence Morand‐Joubert, et al.. (1999). Carriage of GB Virus C/Hepatitis G Virus RNA Is Associated with a Slower Immunologic, Virologic, and Clinical Progression of Human Immunodeficiency Virus Disease in Coinfected Persons. The Journal of Infectious Diseases. 179(4). 783–789. 118 indexed citations

6.

Lefrère, Jean‐Jacques, Jean‐François Cantaloube, Christine Defer, et al.. (1999). Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing. Journal of Virological Methods. 80(1). 33–44. 13 indexed citations

7.

Lefrère, Jean‐Jacques, et al.. (1998). The Risk of Disease Progression Is Determined during the First Year of Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 177(6). 1541–1548. 43 indexed citations

8.

Jj, Lefrère, J. Coste, Christine Defer, et al.. (1998). Screening blood donations for viral genomes: multicenter study of real‐ time simulation using pooled samples on the model of hepatitis C virus RNA detection. Transfusion. 38(10). 915–923. 20 indexed citations

9.

Lefrère, J.‐J., François Lefrère, Martine Mariotti, et al.. (1997). Full or Partial Seroreversion in Patients Infected by Hepatitis C Virus. The Journal of Infectious Diseases. 175(2). 316–322. 65 indexed citations

10.

Lefrère, Jean‐Jacques, Pascale Loiseau, Martine Mariotti, et al.. (1997). Natural History of GBV-C/Hepatitis G Virus Infection Through the Follow-Up of GBV-C/Hepatitis G Virus–Infected Blood Donors and Recipients Studied by RNA Polymerase Chain Reaction and Anti-E2 Serology. Blood. 90(9). 3776–3780. 40 indexed citations

11.

Morand‐Joubert, Laurence, et al.. (1995). Serum anti‐p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid‐dissociated p24 antigen. Journal of Medical Virology. 47(1). 87–91. 7 indexed citations

12.

Goulet, Olivier, et al.. (1990). An unknown source of vitamin K1 in patients on total parenteral nutrition. Clinical Nutrition. 9(2). 85–87. 8 indexed citations

13.

Lefrère, J.‐J., J. Conard, Philippe Mavier, et al.. (1988). Coagulation Assays as Diagnostic Markers of Hepatocellular Carcinoma. Thrombosis and Haemostasis. 60(3). 468–470. 8 indexed citations

14.

Soulier, J P, et al.. (1984). In vivo attempt to consume antithrombin III by I.V. injection of a thrombin-heparin mixture. Thrombosis Research. 34(3). 255–262. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact